U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 17:11:08 UTC 2023
Edited
by admin
on Sat Dec 16 17:11:08 UTC 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type UNKNOWN
Record UNII
KX44A9HM0B
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TORALIZUMAB
INN   USAN  
INN   USAN  
Official Name English
toralizumab [INN]
Common Name English
ANTI-CD40L
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 LIGAND) (HUMAN-MOUSE MONOCLONAL IDEC-131 .GAMMA.1 CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-131 .KAPPA.-CHAIN, DIMER
Systematic Name English
ANTI-CD 154 HUMAN-MOUSE MONOCLONAL ANTIBODY
Common Name English
E-6040
Code English
ANTI-CD154
Code English
TORALIZUMAB [USAN]
Common Name English
IDEC-131
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 LIGAND) (HUMAN-MOUSE MONOCLONAL IDEC-131 .GAMMA.1 CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-131 .KAPPA.-CHAIN, DIMER
Common Name English
ANTI-GP39
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
FDA ORPHAN DRUG 119298
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
FDA ORPHAN DRUG 154302
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C152696
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
PRIMARY
INN
8232
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
PRIMARY
CAS
252662-47-8
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
PRIMARY
ChEMBL
CHEMBL2108747
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
PRIMARY
USAN
MM-32
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
PRIMARY
WIKIPEDIA
TORALIZUMAB
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
PRIMARY
FDA UNII
KX44A9HM0B
Created by admin on Sat Dec 16 17:11:08 UTC 2023 , Edited by admin on Sat Dec 16 17:11:08 UTC 2023
PRIMARY
Related Record Type Details
CD40 LIGAND SOLUBLE
TARGET -> INHIBITOR
CD40 LIGAND RECOMBINANT
TARGET -> INHIBITOR
Related Record Type Details
TORALIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:ESTIMATE CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966